Oregon Health Sciences University
Records under this name other than the patents Oregon Health Sciences University holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Oregon Health Sciences University
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,465,516 | Bodily Lumen Closure Apparatus and Method Held by another company In force · High confidence | In force | High confidence | |
| US 10,738,310 | Treating Cancer Deficient in Fanca, FANCD2, Fance, or Fancg with an Atm Inhibitor Formerly held In force · Medium confidence | In force | Medium confidence | |
| US D646,043 | Bicycle Gutter Held by another company Term ended Term ended Sep 27, 2025 · High confidence | Term ended | Term ended Sep 27, 2025 | High confidence |
| US 8,317,823 | Bodily Lumen Closure Apparatus and Method Held by another company Term ended Term ended Jul 26, 2022 · High confidence | Term ended | Term ended Jul 26, 2022 | High confidence |
| US 9,861,517 | Vessel closure member, delivery apparatus, and method of inserting the member Held by another company Term ended Term ended Jul 26, 2022 · High confidence | Term ended | Term ended Jul 26, 2022 | High confidence |
| US 9,926,360 | Monomeric Recombinant MHC Molecules Useful for Manipulation of Antigen-Specific T-Cells Lapsed on the fee record Ended Mar 27, 2022 · High confidence | Lapsed on the fee record | Ended Mar 27, 2022 | High confidence |
| US 7,628,803 | Implantable Vascular Device Formerly held Lapsed on the fee record Ended Dec 8, 2021 · High confidence | Lapsed on the fee record | Ended Dec 8, 2021 | High confidence |
| US 7,686,842 | Endovascular stent graft Term ended Term ended May 4, 2021 · USPTO record | Term ended | Term ended May 4, 2021 | USPTO record |
| US 8,377,447 | Monomeric Recombinant MHC Molecules Useful for Manipulation of Antigen-Specific T Cells Formerly held Lapsed on the fee record Ended Feb 19, 2021 · High confidence | Lapsed on the fee record | Ended Feb 19, 2021 | High confidence |
| US 7,604,661 | Implantable Vascular Device Held by another company Term ended Term ended Feb 5, 2021 · High confidence | Term ended | Term ended Feb 5, 2021 | High confidence |